See also this year's filing and all EDGAR filings for this company.
PDF Report 0000890908_2013_Dynacq_Healthcare_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000890908, Dynacq Healthcare INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 255,876 |
| 2 | AssetsCurrent | 19,687,070 |
| 3 | PropertyPlantAndEquipment | 6,655,820 |
| 4 | remainder_Assets | 19,586,530 |
| 5 | LongTermLiabilities | 1,074,187 |
| 6 | LiabilitiesCurrent | 14,242,229 |
| 7 | remainder_Liabilities | 87,465 |
| 8 | LaborExpense | 7,176,781 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 0 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 4,399,283 |
| 13 | DepreciationDepletionAndAmortization | 550,643 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 5,576,491 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | 5,504,344 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 46,185,296 |
| 1 | Liabilities | 15,403,881 |
| 2 | Expenses | 17,703,198 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 30,781,415 |
| 5 | NetIncome | -12,198,854 |
| 6 | ComprehensiveNetIncome | -12,198,854 |
| 7 | BaseVar | 42,398,360 |
| 8 | EconomicCapitalRatio | 2.38 |
Edgar->Model Mapping
Feature Distribution
